IRIDEX Corporation (IRIX)

NCM – Real Time Price. Currency in USD

1.04

-0.01 (-0.95%)

At close: May 12, 2026, 4:00 PM EDT

1.03

-0.01 (-0.96%)

After-hours: May 12, 2026, 7:43 PM EDT

05.05.2026

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the first quarter 2026 and provide a business update after the close of trading on May 19, 2026.

07.04.2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a new partnership with EyeProGPO, an ophthalmology-focused group purchasing organization serving ophthalmology practices, ambulatory surgery centers (ASC), and hospitals across the United States.

01.04.2026

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIX incurs narrower year-over-year loss per share in Q4 as growth in retina systems and glaucoma probes boosts revenues, though margins remain pressured by higher costs.

26.03.2026

IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript

26.03.2026

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies

12.03.2026

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

MOUNTAIN VIEW, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the fourth quarter and full year 2025 and provide a business update after the close of trading on March 26, 2026.

02.02.2026

Iridex Announces Plans to Relocate Headquarters

MOUNTAIN VIEW, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced its intent to relocate the Company's headquarters from Mountain View, California to San Jose, California.

Videos

No Data

There is no data to display

Press releases

07.04.2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

26.03.2026

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies

02.02.2026

Iridex Announces Plans to Relocate Headquarters

12.01.2026

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

MOUNTAIN VIEW, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced preliminary unaudited operational and financial results for the fourth quarter and full year ended January 3, 2026.

IRIDEX Corporation (IRIX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

IRIDEX Corporation (IRIX)

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

Iridex Announces Plans to Relocate Headquarters

Videos

No Data

Press releases

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

Iridex Announces Plans to Relocate Headquarters

Videos

No Data

Press releases

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

Search stocks

IRIDEX Corporation (IRIX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

IRIDEX Corporation (IRIX)

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

Iridex Announces Plans to Relocate Headquarters

Videos

No Data

Press releases

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

Iridex Announces Plans to Relocate Headquarters

Videos

No Data

Press releases

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025